Novel mutations in katG gene of a clinical isolate of isoniazid-resistant Mycobacterium tuberculosis

被引:3
|
作者
Purkan [1 ,2 ]
Ihsanawati [1 ]
Syah, Yana M. [1 ]
Retnoningrum, Debbie S. [3 ]
Noer, Achmad S. [1 ]
Shigeoka, Shigeru [4 ]
Natalia, Dessy [1 ]
机构
[1] Bandung Inst Technol, Div Biochem Res, Fac Math & Nat Sci, Bandung 40132, Indonesia
[2] Airlangga Univ, Dept Chem, Fac Sci & Technol, Jl Mulyorejo 60115, Surabaya, Indonesia
[3] Bandung Inst Technol, Sch Pharm, Bandung 40132, Indonesia
[4] Kinki Univ, Plant Mol Physiol Lab, Dept Adv Biosci, Nara 6318505, Japan
关键词
katG; catalase-peroxidase; isoniazid resistance; clinical isolate; Mycobacterium tuberculosis; CATALASE-PEROXIDASE KATG; MODEL;
D O I
10.2478/s11756-011-0162-7
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Most of isoniazid-resistant Mycobacterium tuberculosis evolved due to mutation in the katG gene encoding catalase-peroxidase. A set of new mutations, namely T1310C, G1388T, G1481A, T1553C, and A1660G, which correspond to amino acid substitutions of L437P, R463L, G494D, I518T, and K554E, in the katG gene of the L10 clinical isolate M. tuberculosis was identified. The wild-type and mutant KatG proteins were expressed in Escherichia coli BL21(DE3) as a protein of 80 kDa based on sodium dodecyl sulphate-polyacrylamide gel electrophoresis analysis. The mutant KatG protein exhibited catalase and peroxidase activities of 4.6% and 24.8% toward its wild type, respectively, and retained 19.4% isoniazid oxidation activity. The structure modelling study revealed that these C-terminal mutations might have induced formation of a new turn, perturbing the active site environment and also generated new intramolecular interactions, which could be unfavourable for the enzyme activities.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 50 条
  • [31] Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore - Reply
    Musser, JM
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04): : 1126 - 1127
  • [32] Detecting Novel Genetic Variants Associated with Isoniazid-Resistant Mycobacterium tuberculosis
    Shekar, Sandhya
    Yeo, Zhen Xuan
    Wong, Joshua C. L.
    Chan, Maurice K. L.
    Ong, Danny C. T.
    Tongyoo, Pumipat
    Wong, Sin-Yew
    Lee, Ann S. G.
    PLOS ONE, 2014, 9 (07):
  • [33] Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil
    Cardoso, RF
    Cooksey, RC
    Morlock, GP
    Barco, P
    Cecon, L
    Forestiero, F
    Leite, CQF
    Sato, DN
    Shikama, MD
    Mamizuka, EM
    Hirata, RDC
    Hirata, MH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) : 3373 - 3381
  • [34] Significance of the coexistence of non-codon 315 katG, inhA, and oxyR-ahpC intergenic gene mutations among isoniazid-resistant and multidrug-resistant isolates of Mycobacterium tuberculosis: a report of novel mutations
    Norouzi, Fatemeh
    Moghim, Sharareh
    Farzaneh, ShimaSadat
    Fazeli, Hossein
    Salehi, Mahshid
    Nasr Esfahani, Bahram
    PATHOGENS AND GLOBAL HEALTH, 2022, 116 (01) : 22 - 29
  • [35] Genetic mutations underlying isoniazid-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
    Khan, Anwar Sheed
    Phelan, Jody E.
    Khan, Muhammad Tahir
    Ali, Sajid
    Qasim, Muhammad
    Mohammad, Noor
    Napier, Gary
    Ahmad, Sajjad
    Alam, Jamshed
    Khattak, Baharullah
    Campino, Susana
    Clark, Taane G.
    Khan, Taj Ali
    TUBERCULOSIS, 2023, 138
  • [36] Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants
    Mo, L
    Zhang, W
    Wang, J
    Weng, XH
    Chen, S
    Shao, LY
    Pang, MY
    Chen, ZW
    MICROBIAL DRUG RESISTANCE, 2004, 10 (04) : 269 - 279
  • [37] Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania
    Bakonyte, D
    Baranauskaite, A
    Cicenaite, J
    Sosnovskaja, A
    Stakenas, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) : 2009 - 2011
  • [38] Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis Isolates
    Ho, Yu Min
    Sun, Yong-Jiang
    Wong, Sin-Yew
    Lee, Ann S. G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) : 4010 - 4012
  • [39] Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico
    Viader-Salvadó, JM
    Luna-Aguirre, CM
    Reyes-Ruiz, JM
    Valdez-Leal, R
    Del Bosque-Moncayo, MD
    Tijerina-Menchaca, R
    Guerrero-Olazarán, M
    MICROBIAL DRUG RESISTANCE, 2003, 9 (01) : 33 - 38
  • [40] Evidence for isoniazid-dependent free radical generation catalyzed by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T)
    Wengenack, NL
    Rusnak, F
    BIOCHEMISTRY, 2001, 40 (30) : 8990 - 8996